The board of Jurlique
International today announced the
resignation of Sam McKay as ceo
& president, and the appointment
of Mark Whyman to the position,
effective from 01 Apr.
McKay has agreed to act as an
adviser to the board of Jurlique
International and the wider Pola
Orbis Group for a 12-month period.
Pola Orbis Holdings president
Satoshi Suzuki thanked McKay and
said he was pleased that McKay
had agreed to stay in an advisory
capacity.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Mar 14
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.